The Cellular Thioredoxin-1/Thioredoxin Reductase-1 Driven Oxidoreduction Represents a Chemotherapeutic Target for HIV-1 Entry Inhibition

• Kathrin Reiser ,

  Contributed equally to this work with: Kathrin Reiser, Leen Mathys

  * E-mail: Kathrin.Reiser@ki.se

  Affiliation Karolinska Institute, Department of Laboratory Medicine, Division of Clinical Microbiology, F68, Huddinge, Sweden

  ⨯
• Leen Mathys ,

  Contributed equally to this work with: Kathrin Reiser, Leen Mathys

  Affiliation KU Leuven, Rega Institute for Medical Research, Minderbroederstraat 10, Leuven, Belgium

  ⨯
• Sophie Curbo,

  Affiliation Karolinska Institute, Department of Laboratory Medicine, Division of Clinical Microbiology, F68, Huddinge, Sweden

  ⨯
• Christophe Pannecouque,

  Affiliation KU Leuven, Rega Institute for Medical Research, Minderbroederstraat 10, Leuven, Belgium

  ⨯
• Sam Noppen,

  Affiliation KU Leuven, Rega Institute for Medical Research, Minderbroederstraat 10, Leuven, Belgium

  ⨯
• Sandra Liekens,

  Affiliation KU Leuven, Rega Institute for Medical Research, Minderbroederstraat 10, Leuven, Belgium

  ⨯
• Lars Engman,

  Affiliation Uppsala University, Department of Chemistry–BMC, BOX 576, Uppsala, Sweden

  ⨯
• Mathias Lundberg,

  Affiliation Karolinska Institute, Department of Laboratory Medicine, Division of Clinical Microbiology, F68, Huddinge, Sweden

  ⨯
• Jan Balzarini,

  Affiliation KU Leuven, Rega Institute for Medical Research, Minderbroederstraat 10, Leuven, Belgium

  ⨯
• Anna Karlsson

  Affiliation Karolinska Institute, Department of Laboratory Medicine, Division of Clinical Microbiology, F68, Huddinge, Sweden

  ⨯